Literature DB >> 8630005

Cloning and tissue distribution of the human P2Y1 receptor.

R Janssens1, D Communi, S Pirotton, M Samson, M Parmentier, J M Boeynaems.   

Abstract

Sets of degenerate oligonucleotide primers synthesized on the basis of the best conserved regions of the chick brain P2Y/P2Y1 and the murine neuroblastoma P2U/P2Y2 receptors were used in polymerase chain reaction experiments on human genomic DNA. An amplified fragment of 712 base pairs was then used as a probe to screen a human genomic DNA library. Several clones were isolated and sequencing revealed an intronless 1122 base pair open reading frame. The corresponding amino acid sequence revealed 83% identity with the chick brain P2Y1 receptor and 34% with the murine neuroblastoma P2Y2 receptor. In COS-7 cells transfected with the coding sequence inserted into the pcDNA3 expression vector, 2-methylthioATP and ATP produced a strong stimulation of inositol phosphates, a typical response of a P2Y1 receptor. Northern blot analysis detected a 6.7 kilobase messenger RNA in most human tissues, the strongest signals being observed in prostate and ovary.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8630005     DOI: 10.1006/bbrc.1996.0640

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  28 in total

1.  Expression of P2Y receptors in cell lines derived from the human lung.

Authors:  D Communi; P Paindavoine; G A Place; M Parmentier; J M Boeynaems
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  Effects of extracellular nucleotides and nucleosides on prostate carcinoma cells.

Authors:  R Janssens; J M Boeynaems
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

3.  Adenine nucleotide analogues locked in a Northern methanocarba conformation: enhanced stability and potency as P2Y(1) receptor agonists.

Authors:  R Gnana Ravi; Hak Sung Kim; Jörg Servos; Herbert Zimmermann; Kyeong Lee; Savitri Maddileti; José L Boyer; T Kendall Harden; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2002-05-09       Impact factor: 7.446

4.  Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia.

Authors:  M Tominaga; M Wada; M Masu
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

5.  Structure-activity relationships of bisphosphate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists.

Authors:  E Nandanan; E Camaioni; S Y Jang; Y C Kim; G Cristalli; P Herdewijn; J A Secrist; K N Tiwari; A Mohanram; T K Harden; J L Boyer; K A Jacobson
Journal:  J Med Chem       Date:  1999-05-06       Impact factor: 7.446

6.  Activation of the P2Y1 receptor induces apoptosis and inhibits proliferation of prostate cancer cells.

Authors:  Qiang Wei; Stefano Costanzi; Qiu-Zhen Liu; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2011-05-23       Impact factor: 5.858

7.  [32P]2-iodo-N6-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate ([32P]MRS2500), a novel radioligand for quantification of native P2Y1 receptors.

Authors:  Dayle Houston; Michihiro Ohno; Robert A Nicholas; Kenneth A Jacobson; T Kendall Harden
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

8.  P2Y1 receptor signaling is controlled by interaction with the PDZ scaffold NHERF-2.

Authors:  Sami R Fam; Maryse Paquet; Amanda M Castleberry; Heide Oller; C Justin Lee; Stephen F Traynelis; Yoland Smith; C Chris Yun; Randy A Hall
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-18       Impact factor: 11.205

Review 9.  International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.

Authors:  Maria P Abbracchio; Geoffrey Burnstock; Jean-Marie Boeynaems; Eric A Barnard; José L Boyer; Charles Kennedy; Gillian E Knight; Marta Fumagalli; Christian Gachet; Kenneth A Jacobson; Gary A Weisman
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

Review 10.  Purinergic signalling in the musculoskeletal system.

Authors:  Geoffrey Burnstock; Timothy R Arnett; Isabel R Orriss
Journal:  Purinergic Signal       Date:  2013-08-14       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.